DirectRx joins COPD Foundation’s social responsibility efforts

23 companies now participate in corporate sponsorship program

Mary Chapman avatar

by Mary Chapman |

Share this article:

Share article via email
A person shouts into a megaphone.

The national independent specialty pharmacy DirectRx has joined the COPD Foundation’s Corporate Social Responsibility program to help support patients with chronic obstructive pulmonary disease (COPD) and find better treatments, .

DirectRx’s membership brings to 23 the companies that fall under the foundation’s corporate sponsorship program. The program also includes retail supporters and foundation partners.

“We are proud to stand behind the COPD Foundation and their commitment to supporting and improving the patient’s experience, which directly aligns with our mission to provide unparalleled patient care,” Amanda Berishaj, vice president of clinical services at DirectRx, said in a press release. “The Foundation’s additional focus on supporting and accelerating COPD research and promoting early diagnosis supports our goal of working to continually improve clinical outcomes for our COPD patients.”

Michigan-based DirectRx serves patients with COPD and other complex and chronic health needs. Some 16 million U.S. residents are thought to be affected by the chronic inflammatory lung disorder, the nation’s sixth leading cause of death and the third leading cause globally.

Recommended Reading
antiviral nasal spray | COPD News Today | cells illustration

ENA, COPD Foundation Team Up on INNA-051 Antiviral Nasal Spray

DirectRx, which operates in all 50 states, said it looks forward to following the progress of foundation programs, such as the COPD360Net initiative. The program takes a patient-focused approach to developing and implementing innovative digital health tools, therapies, and medical devices.

The initiative also seeks to innovate the design of clinical trials by targeting specific COPD subpopulations, using new endpoints, and investing in remote digital approaches. It also aims to translate trial results and patient preferences into practice to inform reimbursement policies and optimal care delivery.

“We are so pleased to have this innovative company participate in our Corporate Social Responsibility Program,” said Jean Wright, MD, COPD Foundation’s CEO. “We know our partners share our drive to constantly fuel research, strive for novel advances, and support those living with this chronic illness until we find the cure.”

The nonprofit COPD Foundation also works to support patients with bronchiectasis and nontuberculous mycobacterial lung disease.

DirectRx is accredited by the Accreditation Commission for Health Care, and the Utilization Review Accreditation Commission.